{"url_path":"/sec/whwk/8-k/2026-05-13/item-3-02","section_key":"item-3-02","section_title":"Item 3.02 Unregistered Sales of Equity Securities","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001193125-26-220656-index.html","accession_number":"0001193125-26-220656","cik":"0001422142","ticker":"WHWK","issuer_name":"Whitehawk Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001193125-26-220656-index.html","primary_entity_key":"0001422142","primary_entity_name":"Whitehawk Therapeutics, Inc."},"word_count":88,"has_tables":true,"body_markdown":"Item 3.02\n\nUnregistered Sales of Equity Securities\n\nThe information in Item 1.01 of this Current Report on Form 8-K relating to the PIPE Financing is incorporated herein by reference.\n\nThe shares to be issued by the Company in the PIPE Financing will be issued in private placements exempt from registration under Section 4(a)(2) of the Securities Act promulgated thereunder, because the offer and sale of such securities does not involve a “public offering” as defined in Section 4(a)(2) of the Securities Act, and other applicable requirements were met."}